Table 4 Subgroup analysis: type of treatment and clinical and radiological results

ASES: 0–100 (points)

76.1(± 20.1)

82.7(± 25.78)

0.2086 (n.s.)

NRS: 0–10 (points)

2.5(± 2.5)

1.6(± 2.6)

0.2181 (n.s.)

CMS: 0–100 (points)

76.3(± 7.3)

80.6(± 14.8)

0.1571 (n.s.)

Variation of the calcification (mm)

8.74 (± 7.47)

5.63(± 8.55)

1.0000 (n.s.)

Tendon degeneration (Y/N ratio)

0.33/0.67

0.25/0.75

1.0000 (n.s.)

Subacromial bursitis (Y/N ratio)

0.19/0.81

0.12/0.88

1.0000 (n.s.)

Calcification at follow-up (Y/N ratio)

0.85/0.15

1/0

1.0000 (n.s.)

Calcification at follow-up > 2 mm (Y/N ratio)

0.74/0.26

0.75/0.25

1.0000 (n.s.)

Calcification at follow-up > 5 mm (Y/N ratio)

0.33/0.67

0.37/0.63

1.0000 (n.s.)

Calcification at follow-up > 10 mm (Y/N ratio)

0.11/0.89

0.13/0.87

1.0000 (n.s.)